<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:XTNT="http://xtantmedical.com/20251231"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="xtnt-20251231.xsd" xlink:type="simple"/>
    <context id="From2025-01-01to2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_StockAwardsMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:StockAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_OptionAwardsMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:OptionAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_StockAwardsMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:StockAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_OptionAwardsMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:OptionAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_StockAwardsMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:StockAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_OptionAwardsMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:OptionAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AverageStockAwardsMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageStockAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AverageOptionAwardsMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageOptionAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AverageStockAwardsMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageStockAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AverageOptionAwardsMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageOptionAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AverageStockAwardsMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageStockAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AverageOptionAwardsMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageOptionAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">XTNT:AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_2023-10-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453593</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:RestatementDateAxis">
                    <ecd:RestatementDateAxis.domain>2023-10-01</ecd:RestatementDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2025-01-01to2025-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2025-01-01to2025-12-31" id="Fact000004">0001453593</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl0010">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2025-01-01to2025-12-31" id="Fact000011">Xtant Medical Holdings, Inc.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2025-01-01to2025-12-31" id="Fact000012">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000013">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2025, we did &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_903_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20250101__20251231_zgE7xqmVu0K5"&gt;not&lt;/span&gt; grant any stock options or similar awards as part of our equity compensation program. Our 2025 equity compensation program
consisted of a mix of 50% DSU or RSU awards and 50% PSU awards for our executives and certain other employees, 100% RSU awards for our
other employees, and 100% DSU or RSU awards for our non-employee directors. With respect to the timing of equity awards, we typically
grant all equity awards on the 15&lt;sup&gt;th&lt;/sup&gt; day of the month following corporate approval of the awards. If we decide to grant stock
options or similar awards in the future, we intend not to grant them in anticipation of the release of material nonpublic information
that is likely to result in changes to the price of our common stock, such as a significant positive or negative earnings announcement,
and not time the public release of such information based on stock option grant dates.&lt;/span&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="From2025-01-01to2025-12-31" id="Fact000014">false</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:PvpTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000016">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eecd--PvpTableTextBlock_zWViSIGkS4E2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eecd--PeoTotalCompAmt_zZNLdvq9nkn8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Summary
                                            Compensation Table Total for PEO&lt;sup id="xdx_F5B_zNSNK5O7csfg"&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_485_eecd--PeoActuallyPaidCompAmt_zAK0eA3TpIcg" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation
                                            Actually Paid to PEO&lt;sup id="xdx_F51_z6N0xyAIzQ28"&gt;(2)(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48C_eecd--NonPeoNeoAvgTotalCompAmt_zaJ9spW3DWW1" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average
                                            Summary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation
                                            Table Total for Non-PEO Named Executive Officers&lt;sup id="xdx_F53_zVm14vbuFZ6g"&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_488_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zIY7ilWzmdQ7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average
                                            Compensation Actually Paid to Non-PEO Named Executive Officers&lt;sup id="xdx_F5F_zgy7BiPVcUwd"&gt;(5)(6)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48B_eecd--TotalShareholderRtnAmt_pid_zGwnZdP7LB55" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value
                                            of Initial Fixed $100 Investment&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Based
                                            On Total Shareholder Return&lt;sup id="xdx_F59_zOV761dTxLs9"&gt;(7)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eus-gaap--NetIncomeLoss_zaplXSthIIAe" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net
                                            Income&lt;br/&gt;
 (Loss)&lt;sup id="xdx_F59_zd3ml3NTxpMi"&gt;(8)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41F_20250101__20251231_zUwLmzx8fS9f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,351,676&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,653,976&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,024,950&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,027,089&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;118.79&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,973&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41F_20240101__20241231_zZr9HyvLkTl4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,461,736&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;151,240&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;997,723&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,190&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;67.12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(16,449&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41A_20230101__20231231_zrCa2AeqvSS6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,712,158&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,367,852&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,060,996&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,244,649&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;171.21&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;660&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000017"
      unitRef="USD">1351676</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000018"
      unitRef="USD">1653976</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000019"
      unitRef="USD">1024950</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000020"
      unitRef="USD">1027089</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact000021"
      unitRef="USD">118.79</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000022"
      unitRef="USD">4973</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000023"
      unitRef="USD">2461736</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000024"
      unitRef="USD">151240</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000025"
      unitRef="USD">997723</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000026"
      unitRef="USD">-20190</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000027"
      unitRef="USD">67.12</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000028"
      unitRef="USD">-16449</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000029"
      unitRef="USD">1712158</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000030"
      unitRef="USD">2367852</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000031"
      unitRef="USD">1060996</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000032"
      unitRef="USD">1244649</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000033"
      unitRef="USD">171.21</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000034"
      unitRef="USD">660</us-gaap:NetIncomeLoss>
    <ecd:AdjToPeoCompFnTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000044">&lt;p id="xdx_898_eecd--AdjToPeoCompFnTextBlock_dU_zYZZQFGcTg84" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.25in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BC_ecd--IndividualAxis_ecd--PeoMember_zoNqs9mBdqxl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;PEO&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20250101__20251231_eecd--PeoTotalCompAmt_zvpHp5OQNuL8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Summary Compensation Table Total
    for 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,351,676&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20250101__20251231__ecd--AdjToCompAxis__custom--StockAwardsMember_eecd--AdjToCompAmt_zfhjbrajdOA9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
    awards&lt;sup id="xdx_F47_z7KeZB3kTAj8"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(588,812&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_432_c20250101__20251231__ecd--AdjToCompAxis__custom--OptionAwardsMember_eecd--AdjToCompAmt_zOQw5qsi95qh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Option
    awards&lt;sup id="xdx_F4F_z284d6C1BTq8"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20250101__20251231__ecd--AdjToCompAxis__custom--YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_eecd--AdjToCompAmt_zhdZZtqEKpC3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: left; width: 5%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="text-align: left; width: 75%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Year-end
                                            value of equity awards granted during the year that are &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;outstanding
                                            and unvested&lt;sup id="xdx_F4F_zPOoj9sNAJqk"&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 16%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;308,051&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20250101__20251231__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_eecd--AdjToCompAmt_zeMXcqY2Dxo5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value of equity awards granted in prior years that are outstanding and unvested&lt;sup id="xdx_F4D_zGzDsLoy4wP4"&gt;(d)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;567,538&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20250101__20251231__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_eecd--AdjToCompAmt_z7ZnE7ay4T1l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value of equity awards granted in prior years that vested during the year&lt;sup id="xdx_F49_zlGwJSOrBSJ4"&gt;(e)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,523&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20250101__20251231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_eecd--AdjToCompAmt_zLiMd5VxQl7d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
                                 fair value of equity awards granted in prior years that fail to &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;meet
                                 the applicable vesting conditions during the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20250101__20251231__ecd--AdjToCompAxis__custom--ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_eecd--AdjToCompAmt_zjfrhqi1PQi7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Add:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value
    of dividend equivalents accrued on equity awards during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20250101__20251231_eecd--PeoActuallyPaidCompAmt_zNrnlNXy1j65" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Compensation Actually Paid for
    2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,653,976&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20240101__20241231_eecd--PeoTotalCompAmt_z7iE01aOwA9g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Summary Compensation Table Total
    for 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,461,736&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20240101__20241231__ecd--AdjToCompAxis__custom--StockAwardsMember_eecd--AdjToCompAmt_z1oGyJCs5FGi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
    awards&lt;sup id="xdx_F43_zu1Ng3nEawbc"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,807,132&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20240101__20241231__ecd--AdjToCompAxis__custom--OptionAwardsMember_eecd--AdjToCompAmt_zl6o9N2ny8t5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Option
    awards&lt;sup id="xdx_F48_zGxAAEXaRzL4"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20240101__20241231__ecd--AdjToCompAxis__custom--YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_eecd--AdjToCompAmt_zdszi2D0ByLh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Year-end
    value of equity awards granted during the year that are outstanding and unvested&lt;sup id="xdx_F4F_zf29XcNCiAz"&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;321,918&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20240101__20241231__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_eecd--AdjToCompAmt_zyHIJDP8tbMh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value of equity awards granted in prior years that are outstanding and unvested&lt;sup id="xdx_F4F_ziqCN7yEAFX3"&gt;(d)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(178,969&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20240101__20241231__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_eecd--AdjToCompAmt_znpjRociiZXc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value of equity awards granted in prior years that vested during the year&lt;sup id="xdx_F4B_zyRHhAX6FUqe"&gt;(e)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(646,313&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_eecd--AdjToCompAmt_zsv3IJ6uHQcd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
                                 fair value of equity awards granted in prior years that fail to meet the applicable vesting conditions
                                 during the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.25in"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20240101__20241231__ecd--AdjToCompAxis__custom--ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_eecd--AdjToCompAmt_zFDEhA2faBGl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Add:&lt;/i&gt;
    &lt;/b&gt;Value of dividend equivalents accrued on equity awards during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20240101__20241231_eecd--PeoActuallyPaidCompAmt_zaa95gyXR7c4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Compensation Actually Paid for
    2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;151,240&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20230101__20231231_eecd--PeoTotalCompAmt_zgcsQOPiDMx4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Summary Compensation Table Total
    for 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,712,158&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20230101__20231231__ecd--AdjToCompAxis__custom--StockAwardsMember_eecd--AdjToCompAmt_zqSGMeSyAdL2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 75%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
    awards&lt;sup id="xdx_F4D_zu2HoksQt0u5"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 16%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(209,059&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20230101__20231231__ecd--AdjToCompAxis__custom--OptionAwardsMember_eecd--AdjToCompAmt_zE0xfvvo744h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Option
    awards&lt;sup id="xdx_F43_z1tSKS3GuVzg"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(209,266&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20230101__20231231__ecd--AdjToCompAxis__custom--YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_eecd--AdjToCompAmt_zePKxsWDesx1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Year-end
    value of equity awards granted during the year that are outstanding and unvested&lt;sup id="xdx_F4E_zFYwrfds8OIe"&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;381,459&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20230101__20231231__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_eecd--AdjToCompAmt_zSSJ6fY95wRe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value of equity awards granted in prior years that are outstanding and unvested&lt;sup id="xdx_F4B_zCICX0lX1NAb"&gt;(d)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;346,348&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20230101__20231231__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_eecd--AdjToCompAmt_zNePeu1giWu3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Change
    in fair value of equity awards granted in prior years that vested during the year&lt;sup id="xdx_F44_zG8xHTpyAJaj"&gt;(e)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;346,212&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_eecd--AdjToCompAmt_zqwohjwNP3ij" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
                                 fair value of equity awards granted in prior years that fail to &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;meet
                                 the applicable vesting conditions during the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20230101__20231231__ecd--AdjToCompAxis__custom--ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_eecd--AdjToCompAmt_ztRpinFBZs14" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Add:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value
    of dividend equivalents accrued on equity awards during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20230101__20231231_eecd--PeoActuallyPaidCompAmt_zqfoEpDWC1i8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Compensation Actually Paid for
    2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,367,852&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F06_zZCvjgjDEsdj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_zfq6bZxp08d8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            the total of the amounts reported in the &#x201c;Stock Awards&#x201d; column in the Summary
                                            Compensation Table for the applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0F_z8jgy1P5h9Y5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1C_zAFW5nNYi9Bh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            the total of the amounts reported in the &#x201c;Option Awards&#x201d; column in the Summary
                                            Compensation Table for the applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F08_z6rGJezeSk9f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_zq0g838r3C6d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            the year-end value of equity awards granted during the applicable year that are outstanding
                                            and unvested as of the end of such applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0C_zoo7zMaMI9H7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_zgRcw9e28x4i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            the amount of change as of the end of the applicable year (from the end of the prior fiscal
                                            year) in fair value of any equity awards granted in prior years that are outstanding and
                                            unvested as of the end of such applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0D_zScRAMVYMi37" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F16_z241bH6bgkYi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            the amount of change as of the vesting date (from the end of the prior fiscal year) in fair
                                            value of any equity awards granted in prior years that vested during the applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember"
      decimals="0"
      id="Fact000046"
      unitRef="USD">1351676</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_StockAwardsMember_ecd_PeoMember"
      decimals="0"
      id="Fact000048"
      unitRef="USD">-588812</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_OptionAwardsMember_ecd_PeoMember"
      decimals="0"
      id="Fact000050"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember"
      decimals="0"
      id="Fact000052"
      unitRef="USD">308051</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember"
      decimals="0"
      id="Fact000054"
      unitRef="USD">567538</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember"
      decimals="0"
      id="Fact000056"
      unitRef="USD">15523</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_ecd_PeoMember"
      decimals="0"
      id="Fact000058"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_ecd_PeoMember"
      decimals="0"
      id="Fact000060"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember"
      decimals="0"
      id="Fact000062"
      unitRef="USD">1653976</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember"
      decimals="0"
      id="Fact000064"
      unitRef="USD">2461736</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_StockAwardsMember_ecd_PeoMember"
      decimals="0"
      id="Fact000066"
      unitRef="USD">-1807132</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_OptionAwardsMember_ecd_PeoMember"
      decimals="0"
      id="Fact000068"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember"
      decimals="0"
      id="Fact000070"
      unitRef="USD">321918</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember"
      decimals="0"
      id="Fact000072"
      unitRef="USD">-178969</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember"
      decimals="0"
      id="Fact000074"
      unitRef="USD">-646313</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_ecd_PeoMember"
      decimals="0"
      id="Fact000076"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_ecd_PeoMember"
      decimals="0"
      id="Fact000078"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember"
      decimals="0"
      id="Fact000080"
      unitRef="USD">151240</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember"
      decimals="0"
      id="Fact000082"
      unitRef="USD">1712158</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_StockAwardsMember_ecd_PeoMember"
      decimals="0"
      id="Fact000084"
      unitRef="USD">-209059</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_OptionAwardsMember_ecd_PeoMember"
      decimals="0"
      id="Fact000086"
      unitRef="USD">-209266</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember"
      decimals="0"
      id="Fact000088"
      unitRef="USD">381459</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember"
      decimals="0"
      id="Fact000090"
      unitRef="USD">346348</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember"
      decimals="0"
      id="Fact000092"
      unitRef="USD">346212</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_ecd_PeoMember"
      decimals="0"
      id="Fact000094"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_ecd_PeoMember"
      decimals="0"
      id="Fact000096"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember"
      decimals="0"
      id="Fact000098"
      unitRef="USD">2367852</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000105">&lt;p id="xdx_89E_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zF8yV7rySmBb" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.25in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B9_ecd--IndividualAxis_ecd--NonPeoNeoMember_zbXPiGwY9rz2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average
    Non-PEO Named Executive Officers&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20250101__20251231_eecd--NonPeoNeoAvgTotalCompAmt_zMC0gqDJfieg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average Summary Compensation Table
    Total for 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,024,950&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20250101__20251231__ecd--AdjToCompAxis__custom--AverageStockAwardsMember_eecd--AdjToCompAmt_zPvf1voDrfJ6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 75%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    stock awards&lt;sup id="xdx_F43_zQBiC11l23dd"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 16%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(414,131&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20250101__20251231__ecd--AdjToCompAxis__custom--AverageOptionAwardsMember_eecd--AdjToCompAmt_zAYGPaJ5cLf7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    option awards&lt;sup id="xdx_F4C_zlprggsjugZb"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_432_c20250101__20251231__ecd--AdjToCompAxis__custom--AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_eecd--AdjToCompAmt_zc8Lyex4TB6h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    year-end value of equity awards granted during the year that are outstanding and unvested&lt;sup id="xdx_F47_zwvtdhXNl559"&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;216,662&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20250101__20251231__ecd--AdjToCompAxis__custom--AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_eecd--AdjToCompAmt_zb9LKG8OK0vf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    change in fair value of equity awards granted in prior years that are outstanding and unvested&lt;sup id="xdx_F48_zJiOcu34g8Vd"&gt;(d)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;177,626&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20250101__20251231__ecd--AdjToCompAxis__custom--AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_eecd--AdjToCompAmt_zXkhKeQcX5be" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    change in fair value of equity awards granted in prior years that vested during the year&lt;sup id="xdx_F45_zG48NKqhNTS1"&gt;(e)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,982&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20250101__20251231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_eecd--AdjToCompAmt_z3h5EQJiseC6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deduct:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average
    fair value of equity awards granted in prior years that fail to meet the applicable vesting conditions during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_432_c20250101__20251231__ecd--AdjToCompAxis__custom--AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_eecd--AdjToCompAmt_z5lFC4Kuv4f7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Add:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average
    value of dividend equivalents accrued on equity awards during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20250101__20251231_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zPBMRns144O7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average Compensation Actually Paid
    for 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,027,089&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20240101__20241231_eecd--NonPeoNeoAvgTotalCompAmt_zcfbRDJxNO7b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average Summary Compensation Table
    Total for 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;997,723&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_432_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageStockAwardsMember_eecd--AdjToCompAmt_zThW8zTEMuZg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    stock awards&lt;sup id="xdx_F47_zsAKuEuv7Hul"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(440,672&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageOptionAwardsMember_eecd--AdjToCompAmt_zIJibSsV2J8e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    option awards&lt;sup id="xdx_F43_zwFORkx9qQ51"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_eecd--AdjToCompAmt_zMWyEY9T44F" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    year-end value of equity awards granted during the year that are outstanding and unvested&lt;sup id="xdx_F47_zjrlEWgQ89ca"&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;51,483&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_eecd--AdjToCompAmt_zH56xU5tYs8h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    change in fair value of equity awards granted in prior years that are outstanding and unvested&lt;sup id="xdx_F48_zYoryFRJq0h8"&gt;(d)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(164,116&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_eecd--AdjToCompAmt_zhBVr0mJQhmh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    change in fair value of equity awards granted in prior years that vested during the year&lt;sup id="xdx_F49_zkmR337Rqtk2"&gt;(e)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(50,094&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_eecd--AdjToCompAmt_z9FtaDbMr076" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    fair value of equity awards granted in prior years that fail to meet the applicable vesting conditions during the year&lt;sup id="xdx_F46_ze6FrgHz8ry1"&gt;(f)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;414,514&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_432_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_eecd--AdjToCompAmt_zBv7brMeSJU" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Add:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average
    value of dividend equivalents accrued on equity awards during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20240101__20241231_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zhMGxr55ggjk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average Compensation Actually Paid
    for 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(20,190&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20230101__20231231_eecd--NonPeoNeoAvgTotalCompAmt_zL4uTNhzRXCk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average Summary Compensation Table
    Total for 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,060,996&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageStockAwardsMember_eecd--AdjToCompAmt_zuDG8WohsTp2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    stock awards&lt;sup id="xdx_F43_zBiTrkSMnXq"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(174,872&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageOptionAwardsMember_eecd--AdjToCompAmt_ztzJ49QiLG33" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Deduct&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    option awards&lt;sup id="xdx_F45_zCXsfB2ZZ3Fc"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(176,503&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_eecd--AdjToCompAmt_zk7xXJkytVoa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    year-end value of equity awards granted during the year that are outstanding and unvested&lt;sup id="xdx_F42_zUED9A1A0Fs"&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;382,803&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_eecd--AdjToCompAmt_ztLrWQtrHNya" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    change in fair value of equity awards granted in prior years that are outstanding and unvested&lt;sup id="xdx_F4F_zL9CN0aNanmd"&gt;(d)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;94,066&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_eecd--AdjToCompAmt_zAlgm4xOZoGg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Add&lt;/i&gt;&lt;/b&gt;:
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average
    change in fair value of equity awards granted in prior years that vested during the year&lt;sup id="xdx_F49_zsiHaFe0deg6"&gt;(e)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,159&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_eecd--AdjToCompAmt_zYXRP7hTA8H6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deduct:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average
    fair value of equity awards granted in prior years that fail to meet the applicable vesting conditions during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_eecd--AdjToCompAmt_zVWvC4Pobxnj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Add:&lt;/i&gt;&lt;/b&gt;
    Average value of dividend equivalents accrued on equity awards during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20230101__20231231_eecd--NonPeoNeoAvgCompActuallyPaidAmt_z79NABBOeQej" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average Compensation Actually Paid
    for 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,244,649&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0F_zxZgEkW2KEf1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1D_zx4PJaRQoIa7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            the average of the total of the amounts reported in the &#x201c;Stock Awards&#x201d; column
                                            in the Summary Compensation Table for the applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0E_zsrsxvhhavr8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1D_zPmvMEVrw9z4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            the average of the total of the amounts reported in the &#x201c;Option Awards&#x201d; column
                                            in the Summary Compensation Table for the applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F00_z6r69sJQ7pf6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1F_zsr1BLWMZoFc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            the average of the year-end value of equity awards granted during the applicable year that
                                            are outstanding and unvested as of the end of such applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F03_z3JXGNxI3sHk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F19_zeH2mIgcNpY5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            the average of the amount of change as of the end of the applicable year (from the end of
                                            the prior fiscal year) in fair value of any equity awards granted in prior years that are
                                            outstanding and unvested as of the end of such applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0E_zRIXTqLylKeh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1A_zCseewXFmVSh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            the average of the amount of change as of the vesting date (from the end of the prior fiscal
                                            year) in fair value of any equity awards granted in prior years that vested during the applicable
                                            year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000107"
      unitRef="USD">1024950</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_AverageStockAwardsMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000109"
      unitRef="USD">-414131</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_AverageOptionAwardsMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000111"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000113"
      unitRef="USD">216662</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000115"
      unitRef="USD">177626</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000117"
      unitRef="USD">21982</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000119"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000121"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000123"
      unitRef="USD">1027089</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000125"
      unitRef="USD">997723</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AverageStockAwardsMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000127"
      unitRef="USD">-440672</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AverageOptionAwardsMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000129"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000131"
      unitRef="USD">51483</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000133"
      unitRef="USD">-164116</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000135"
      unitRef="USD">-50094</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000137"
      unitRef="USD">414514</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000139"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000141"
      unitRef="USD">-20190</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000143"
      unitRef="USD">1060996</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AverageStockAwardsMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000145"
      unitRef="USD">-174872</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AverageOptionAwardsMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000147"
      unitRef="USD">-176503</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000149"
      unitRef="USD">382803</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000151"
      unitRef="USD">94066</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000153"
      unitRef="USD">58159</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000155"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000157"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000159"
      unitRef="USD">1244649</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000166">&lt;p id="xdx_891_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zVAZkoYjlA56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_8B3_zrxtsGSnkcDj"&gt;Compensation
Actually Paid and TSR&lt;/span&gt;&lt;/i&gt;. As demonstrated by the following graph, the amount of compensation actually paid to our NEOs is aligned with
our cumulative TSR over the three-year period presented in the Pay versus Performance table above. The alignment of compensation actually
paid with our cumulative TSR is because a significant portion of the compensation actually paid to our NEOs is comprised of equity awards,
the value of which is driven by our stock price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;img alt="" src="formdef14a_010.jpg" style="width: 550px"/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000168">&lt;p id="xdx_890_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_z7zvqzxRsup6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_8B8_zzq2Yjuj89yi"&gt;Compensation
Actually Paid and Net Income (Loss)&lt;/span&gt;&lt;/i&gt;. As demonstrated by the following graph, the amount of compensation actually paid to our NEOs
is somewhat aligned with our net income (loss) for each of the three years presented in the Pay versus Performance table.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;img alt="" src="formdef14a_011.jpg" style="width: 550px"/&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:RestatementDoesNotRequireRecoveryTextBlock
      contextRef="From2025-01-012025-12-31_2023-10-01"
      id="Fact000169">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
as of October 1, 2023, we adopted a clawback policy to provide for a mandatory clawback of incentive compensation paid to current and
former executives under certain circumstances in the event a financial metric used to determine the vesting or payment of incentive compensation
to an executive was calculated incorrectly and resulted in a financial restatement. This policy complies with SEC and NYSE American rules
adopted pursuant to the Dodd-Frank Wall Street and Consumer Protection Act.&lt;/span&gt;</ecd:RestatementDoesNotRequireRecoveryTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000017"
          xlink:label="Fact000017"
          xlink:type="locator"/>
        <link:footnote id="Footnote000035" xlink:label="Footnote000035" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts
                                            reported represent the Summary Compensation Table total for our CEO for each of the years
                                            presented. See &#x201c;<xhtml:i>Executive Compensation&#x2014;Summary Compensation Table.</xhtml:i>&#x201d;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000023"
          xlink:label="Fact000023"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000018"
          xlink:label="Fact000018"
          xlink:type="locator"/>
        <link:footnote id="Footnote000036" xlink:label="Footnote000036" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts
                                            reported represent compensation actually paid to our CEO for each of the years presented.
                                            The dollar amounts in this column do not reflect the actual amount of compensation earned
                                            by or paid to our CEO during the applicable year.</link:footnote>
        <link:footnote id="Footnote000037" xlink:label="Footnote000037" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Compensation
                                            actually paid to our PEO consists of the following amounts deducted from or added to the
                                            Summary Compensation Table total for our CEO for each of the years presented:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000037"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000024"
          xlink:label="Fact000024"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000037"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000030"
          xlink:label="Fact000030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000037"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000019"
          xlink:label="Fact000019"
          xlink:type="locator"/>
        <link:footnote id="Footnote000038" xlink:label="Footnote000038" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Average
                                            Summary Compensation Table total for non-PEO named executive officers reflects the average
                                            Summary Compensation Table total for Scott C. Neils and Mark A. Schallenberger for 2025,
                                            for Scott C. Neils, Mark A. Schallenberger and Kevin D. Brandt (a former executive officer)
                                            for 2024, and Kevin D. Brandt and Mark A. Schallenberger for 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000038"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000025"
          xlink:label="Fact000025"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000038"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000038"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000020"
          xlink:label="Fact000020"
          xlink:type="locator"/>
        <link:footnote id="Footnote000039" xlink:label="Footnote000039" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
                                            amounts in this column represent the average compensation actually paid to the non-PEOs for
                                            each of the years presented. The dollar amounts in this column do not reflect the actual
                                            average amount of compensation earned by or paid to the non-PEOs during the applicable year.</link:footnote>
        <link:footnote id="Footnote000040" xlink:label="Footnote000040" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Average
                                            compensation actually paid to non-PEO named executive officers reflects the average compensation
                                            actually paid to Scott C. Neils and Mark A. Schallenberger for 2025, Scott C. Neils, Mark
                                            A. Schallenberger and Kevin D. Brandt for 2024, and Kevin D. Brandt and Mark A. Schallenberger
                                            for 2023 and consists of the following average amounts deducted from and added to the average
                                            Summary Compensation Table total for the non-PEO named executive officers for each of the
                                            years presented:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000020"
          xlink:to="Footnote000039"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000020"
          xlink:to="Footnote000040"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000026"
          xlink:label="Fact000026"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000039"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000040"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000032"
          xlink:label="Fact000032"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000032"
          xlink:to="Footnote000039"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000032"
          xlink:to="Footnote000040"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000021"
          xlink:label="Fact000021"
          xlink:type="locator"/>
        <link:footnote id="Footnote000041" xlink:label="Footnote000041" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
                                            total shareholder return is calculated based on the difference between our common stock price
                                            at the end of the measurement period and our common stock price at the beginning of the measurement
                                            period and assuming the investment of $100 on December 31, 2022. Because we do not pay any
                                            dividends, our total stockholder return does not assume the reinvestment of dividends.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000027"
          xlink:label="Fact000027"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000033"
          xlink:label="Fact000033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000033"
          xlink:to="Footnote000041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000022"
          xlink:label="Fact000022"
          xlink:type="locator"/>
        <link:footnote id="Footnote000042" xlink:label="Footnote000042" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts
                                            reported represent the amount of net income (loss) reflected in our audited consolidated
                                            financial statements for the applicable year and is presented in thousands.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000028"
          xlink:label="Fact000028"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000028"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000034"
          xlink:label="Fact000034"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000034"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000048"
          xlink:label="Fact000048"
          xlink:type="locator"/>
        <link:footnote id="Footnote000099" xlink:label="Footnote000099" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
                                            the total of the amounts reported in the &#x201c;Stock Awards&#x201d; column in the Summary
                                            Compensation Table for the applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000048"
          xlink:to="Footnote000099"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000066"
          xlink:label="Fact000066"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000066"
          xlink:to="Footnote000099"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000084"
          xlink:label="Fact000084"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000084"
          xlink:to="Footnote000099"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000050"
          xlink:label="Fact000050"
          xlink:type="locator"/>
        <link:footnote id="Footnote000100" xlink:label="Footnote000100" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
                                            the total of the amounts reported in the &#x201c;Option Awards&#x201d; column in the Summary
                                            Compensation Table for the applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000050"
          xlink:to="Footnote000100"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000068"
          xlink:label="Fact000068"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000068"
          xlink:to="Footnote000100"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000086"
          xlink:label="Fact000086"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000086"
          xlink:to="Footnote000100"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000052"
          xlink:label="Fact000052"
          xlink:type="locator"/>
        <link:footnote id="Footnote000101" xlink:label="Footnote000101" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
                                            the year-end value of equity awards granted during the applicable year that are outstanding
                                            and unvested as of the end of such applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000052"
          xlink:to="Footnote000101"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000070"
          xlink:label="Fact000070"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000070"
          xlink:to="Footnote000101"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000088"
          xlink:label="Fact000088"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000088"
          xlink:to="Footnote000101"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000054"
          xlink:label="Fact000054"
          xlink:type="locator"/>
        <link:footnote id="Footnote000102" xlink:label="Footnote000102" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
                                            the amount of change as of the end of the applicable year (from the end of the prior fiscal
                                            year) in fair value of any equity awards granted in prior years that are outstanding and
                                            unvested as of the end of such applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000054"
          xlink:to="Footnote000102"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000072"
          xlink:label="Fact000072"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000072"
          xlink:to="Footnote000102"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000090"
          xlink:label="Fact000090"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000090"
          xlink:to="Footnote000102"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000056"
          xlink:label="Fact000056"
          xlink:type="locator"/>
        <link:footnote id="Footnote000103" xlink:label="Footnote000103" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
                                            the amount of change as of the vesting date (from the end of the prior fiscal year) in fair
                                            value of any equity awards granted in prior years that vested during the applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000056"
          xlink:to="Footnote000103"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000074"
          xlink:label="Fact000074"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000074"
          xlink:to="Footnote000103"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000092"
          xlink:label="Fact000092"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000092"
          xlink:to="Footnote000103"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000109"
          xlink:label="Fact000109"
          xlink:type="locator"/>
        <link:footnote id="Footnote000160" xlink:label="Footnote000160" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
                                            the average of the total of the amounts reported in the &#x201c;Stock Awards&#x201d; column
                                            in the Summary Compensation Table for the applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000109"
          xlink:to="Footnote000160"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000127"
          xlink:label="Fact000127"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000127"
          xlink:to="Footnote000160"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000145"
          xlink:label="Fact000145"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000145"
          xlink:to="Footnote000160"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000111"
          xlink:label="Fact000111"
          xlink:type="locator"/>
        <link:footnote id="Footnote000161" xlink:label="Footnote000161" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
                                            the average of the total of the amounts reported in the &#x201c;Option Awards&#x201d; column
                                            in the Summary Compensation Table for the applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000111"
          xlink:to="Footnote000161"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000129"
          xlink:label="Fact000129"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000129"
          xlink:to="Footnote000161"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000147"
          xlink:label="Fact000147"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000147"
          xlink:to="Footnote000161"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000113"
          xlink:label="Fact000113"
          xlink:type="locator"/>
        <link:footnote id="Footnote000162" xlink:label="Footnote000162" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
                                            the average of the year-end value of equity awards granted during the applicable year that
                                            are outstanding and unvested as of the end of such applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000113"
          xlink:to="Footnote000162"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000131"
          xlink:label="Fact000131"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000131"
          xlink:to="Footnote000162"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000149"
          xlink:label="Fact000149"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000149"
          xlink:to="Footnote000162"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000115"
          xlink:label="Fact000115"
          xlink:type="locator"/>
        <link:footnote id="Footnote000163" xlink:label="Footnote000163" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
                                            the average of the amount of change as of the end of the applicable year (from the end of
                                            the prior fiscal year) in fair value of any equity awards granted in prior years that are
                                            outstanding and unvested as of the end of such applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000115"
          xlink:to="Footnote000163"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000133"
          xlink:label="Fact000133"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000133"
          xlink:to="Footnote000163"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000151"
          xlink:label="Fact000151"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000151"
          xlink:to="Footnote000163"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000117"
          xlink:label="Fact000117"
          xlink:type="locator"/>
        <link:footnote id="Footnote000164" xlink:label="Footnote000164" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
                                            the average of the amount of change as of the vesting date (from the end of the prior fiscal
                                            year) in fair value of any equity awards granted in prior years that vested during the applicable
                                            year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000117"
          xlink:to="Footnote000164"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000135"
          xlink:label="Fact000135"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000135"
          xlink:to="Footnote000164"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000153"
          xlink:label="Fact000153"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000153"
          xlink:to="Footnote000164"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
